SLFN12 and myeloid sarcoma: A study involving isolated CD4+ and CD8+ T cells from multiple sclerosis (MS) patients indicated regions of hypermethylation in SLFN12 owing to an overall decrease in SLFN12 expression in whole blood samples of multiple sclerosis patients when compared to controls.